Showing results (11-20 of 88) with videos related to
Sort By:
Pageof 9
Neurodegenerative Disease Management|April 11, 2018
Age/disease duration influence on activities of daily living and quality of life after levodopa-carbidopa intestinal gel in Parkinson's diseaseAngelo Antonini, Weining Z Robieson, Lars Bergmann, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 18, 2025
Ethnographic evaluation of usability, understandability, and acceptance of the MY PD-CARE digital tool to facilitate Parkinson's disease symptom tracking and patients' and care partners' communications with the treating healthcare professional: the SELF-AWARE studyAngelo Antonini, Tove Henriksen, Amelia Hursey, et al.Seizure|November 10, 2005
The LAM-SAFE Study: lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adultsBernhard J Steinhoff, Michael A Ueberall, Hartmut Siemes, et al.Cells|April 11, 2020
Major Adverse Kidney Events Are Associated with the Aquaporin 5 -1364A/C Promoter Polymorphism in Sepsis: A Prospective Validation StudyLars Bergmann, Hartmuth Nowak, Winfried Siffert, et al.BMC Anesthesiology|July 31, 2016
Phrenic nerve block caused by interscalene brachial plexus block: breathing effects of different sites of injectionLars Bergmann, Stefan Martini, Miriam Kesselmeier, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 14, 2015
Shortening of freezing cycles provides equal outcome to standard ablation procedure using second-generation 28 mm cryoballoon after 15-month follow-upJürgen Tebbenjohanns, Claudia Höfer, Lars Bergmann, et al.Frontiers in Immunology|December 24, 2019
The Aquaporin 5 -1364A/C Promoter Polymorphism Is Associated With Cytomegalovirus Infection Risk in Kidney Transplant RecipientsTim Rahmel, Hartmuth Nowak, Katharina Rump, et al.Antibiotics (Basel, Switzerland)|January 28, 2026
Duration Matters: Tailoring Antibiotic Therapy for Ventilator-Associated PneumoniaTim Rahmel, Isabella Traut, Lars Bergmann, et al.Plos One|February 13, 2020
Long-term mortality and outcome in hospital survivors of septic shock, sepsis, and severe infections: The importance of aftercareTim Rahmel, Stefanie Schmitz, Hartmuth Nowak, et al.Frontiers in Immunology|September 3, 2021
Corrigendum: The Aquaporin 5 -1364A/C Promoter Polymorphism Is Associated With Cytomegalovirus Infection Risk in Kidney Transplant RecipientsTim Rahmel, Hartmuth Nowak, Sandra Frisenda, et al.Pageof 9